Cargando…

COVID-19 and the risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study

BACKGROUND: An increasing number of studies have elucidated a close nexus between COVID-19 phenotypes and neuromyelitis optica spectrum disorder (NMOSD), yet the causality between them remains enigmatic. METHODS: In this study, we conducted a Mendelian randomization (MR) analysis employing summary d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Dongren, Du, Qin, Wang, Rui, Shi, Ziyan, Chen, Hongxi, Zhou, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414539/ https://www.ncbi.nlm.nih.gov/pubmed/37575255 http://dx.doi.org/10.3389/fimmu.2023.1207514

Ejemplares similares

Visual disability in neuromyelitis optica spectrum disorders: prognostic prediction models
por: Luo, Wenqin, et al.
Publicado: (2023)

The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases
por: Wang, Xiaofei, et al.
Publicado: (2022)

Mortality of neuromyelitis optica spectrum disorders in a Chinese population
por: Du, Qin, et al.
Publicado: (2021)

Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders
por: Shi, Ziyan, et al.
Publicado: (2022)

Effects of pregnancy on neuromyelitis optica spectrum disorder and predictors of related attacks
por: Du, Qin, et al.
Publicado: (2022)

Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder
por: Luo, Wenqin, et al.
Publicado: (2023)

Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
por: Kong, Lingyao, et al.
Publicado: (2022)

Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study
por: Lang, Yanlin, et al.
Publicado: (2023)

CD8(+) T cell subpopulations and pro‐inflammatory cytokines in neuromyelitis optica spectrum disorder
por: Shi, Ziyan, et al.
Publicado: (2020)

Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
por: Kong, Lingyao, et al.
Publicado: (2022)

Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study
por: Cai, Linjun, et al.
Publicado: (2022)

Causal relationship of COVID-19 on Alzheimer’s disease: an updated Mendelian randomization study
por: Sun, Dongren, et al.
Publicado: (2023)

Immune Repertoire Profiling Reveals Its Clinical Application Potential and Triggers for Neuromyelitis Optica Spectrum Disorders
por: Miao, Yu, et al.
Publicado: (2023)

Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum Disorder
por: Du, Chen, et al.
Publicado: (2021)

Association between COVID‐19 and myasthenia gravis (MG): A genetic correlation and Mendelian randomization study
por: Sun, Dongren, et al.
Publicado: (2023)

Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders
por: Zhang, Shanchao, et al.
Publicado: (2022)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Research hotspots and trends on neuromyelitis optica spectrum disorders: insights from bibliometric analysis
por: Chen, Xin, et al.
Publicado: (2023)

Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
por: Miyamoto, Katsuichi, et al.
Publicado: (2023)

Expression and Clinical Correlation Analysis Between Repulsive Guidance Molecule a and Neuromyelitis Optica Spectrum Disorders
por: Tang, Jinhua, et al.
Publicado: (2022)

Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder
por: Hu, Yacen, et al.
Publicado: (2022)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

Muscle damage in patients with neuromyelitis optica spectrum disorder
por: Chen, Hong-xi, et al.
Publicado: (2017)

Neuromyelitis Optica Spectrum Disorder With Anti-Aquaporin-4 Antibody: Outcome Prediction Models
por: Wang, Liang, et al.
Publicado: (2022)

A Comprehensive Review on the Role of Genetic Factors in Neuromyelitis Optica Spectrum Disorder
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders
por: Tabansky, Inna, et al.
Publicado: (2022)

Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women
por: Han, Lin, et al.
Publicado: (2022)

Effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With Neuromyelitis Optica Spectrum Disorder
por: Liu, Ye, et al.
Publicado: (2021)

Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder
por: Chang, Haoxiao, et al.
Publicado: (2021)

Sleep abnormality in neuromyelitis optica spectrum disorder
por: Song, Yijun, et al.
Publicado: (2015)

Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)

Treatment of Neuromyelitis Optica Spectrum Disorders
por: Chan, Koon-Ho, et al.
Publicado: (2021)

Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)

Editorial: Advances in neuromyelitis optica spectrum disorders
por: Cai, Yu, et al.
Publicado: (2022)

The Emerging Role of Microglia in Neuromyelitis Optica
por: Chen, Tingjun, et al.
Publicado: (2021)

Aquaporin 4-positive neuromyelitis optica spectrum disorder with meningoencephalitis-like onset: A case report
por: Bu, Yi, et al.
Publicado: (2022)

Therapeutic Response and Possible Biomarkers in Acute Attacks of Neuromyelitis Optica Spectrum Disorders: A Prospective Observational Study
por: Wang, Jingqi, et al.
Publicado: (2021)

Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder
por: Uzonyi, Barbara, et al.
Publicado: (2021)

Association of Circulating Follicular Helper T Cells and Serum CXCL13 With Neuromyelitis Optica Spectrum Disorders
por: Yang, Xiaoyan, et al.
Publicado: (2021)

Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
por: Chen, Chen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dcl3eo7gnq935tc66q7hdbkngf